Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.
Related Research units
Abstract
Although most guidelines recommend the use of cholinesterase inhibitors (ChEIs) for mild to moderate Alzheimer's Disease, only a small proportion of affected patients receive these drugs. We aimed to study if geriatric comorbidity and polypharmacy influence the prescription of ChEIs in patients with dementia in Germany.
Bibliographical data
| Original language | English |
|---|---|
| ISSN | 1471-244X |
| DOIs | |
| Publication status | Published - 2011 |
| pubmed | 22145796 |
|---|
